← Back to Search

Behavioural Intervention

Virtual Reality Therapy for Anxiety

N/A
Recruiting
Led By Tsai Jack, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Awards & highlights

Study Summary

This trial will test if a VR intervention can help reduce anxiety symptoms in college students, by having them undergo six VR sessions over the course of three weeks.

Who is the study for?
This trial is for students at The University of Texas Health Science Center School of Public Health San Antonio campus who can speak English and have a mild level of anxiety. Students with photosensitive epilepsy, vision or balance issues, or those currently in therapy for anxiety or who were treated within the last year cannot participate.Check my eligibility
What is being tested?
The study is testing 'gameChange', a virtual reality therapy program, to see if it helps reduce anxiety symptoms over six sessions within three weeks. It also looks at how this VR treatment might improve students' confidence in their academic abilities.See study design
What are the potential side effects?
Since this intervention involves virtual reality, some participants may experience temporary discomfort like dizziness, nausea, or headaches during the VR sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Psychomotor agitation such as Fidgeting
Change in Psychomotor agitation such as Rubbing hands/neck/head
Change in Psychomotor agitation such as pacing
+8 more
Secondary outcome measures
Change in acceptability as assessed by the rating on a short questionnaire
Change in perceived presence in the virtual environment (as indicated by continuous score on the Igroup Presence Questionnaire (IPQ)
Change in self-reported academic performance as assessed by the Motivated Strategies for Learning Questionnaire (MSLQ)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: gameChangeExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,860 Total Patients Enrolled
1 Trials studying Anxiety
20 Patients Enrolled for Anxiety
Tsai Jack, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

gameChange (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05319509 — N/A
Anxiety Research Study Groups: gameChange
Anxiety Clinical Trial 2023: gameChange Highlights & Side Effects. Trial Name: NCT05319509 — N/A
gameChange (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319509 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially qualify to participate in this research endeavor?

"This research effort is searching for 100 participants, between 18 and 30 years of age, who have been diagnosed with anxiety. To qualify to join this study, individuals must also be fluent in English and score a minimum of three on the GAD-2 scale as well as be enrolled at The University of Texas Health Science Center School of Public Health San Antonio regional campus."

Answered by AI

Is there an opportunity for individuals to partake in this research project?

"According to the official record on clinicaltrials.gov, this trial is actively seeking participants with an initial posting date of April 1st 2022 and a recent edit made on April 12th 2022."

Answered by AI

What are the main goals of this experiment?

"The primary efficacy endpoint of this clinical trial, monitored over three weeks (during six sessions), will be the alteration in state anxiety as evaluated through the Liebowitz Social anxiety Scale-Self Report. Secondary objectives include a change in self-reported academic performance based on responses to the Motivated Strategies for Learning Questionnaire (MSLQ) with a maximum score of 63; an adjustment in perceived presence within virtual environments via continuous scoring from Igroup Presence Questionnaire (IPQ); and alterations to acceptability gauged by ratings given on a short user questionnaire developed by gameChange which is scored from one to five, with higher numbers indicating stronger agreement"

Answered by AI

Is the age range for participation in this research inclusive of individuals aged 50 and above?

"This clinical study enforces an age restriction, where the minimum permissible age is 18 and the maximum allowable age is 30."

Answered by AI

What is the optimal number of participants for this clinical experiment?

"Affirmative. Clinicaltrials.gov documents confirm that this medical trial, first published on April 1st 2022, is actively recruiting volunteers. Approximately 100 participants need to be enrolled from the single site participating in this study."

Answered by AI

Who else is applying?

What state do they live in?
Minnesota
Texas
How old are they?
18 - 65
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Most responsive sites:
  1. The University of Texas Health Science Center at Houston: < 48 hours
Typically responds via
Email
Average response time
  • < 2 Days
~33 spots leftby Apr 2025